Skip to content
Lower risk Medical device recall · FDA · Published December 22, 2020

Cytocell Aquarius LPH 511-A CRLF2 Distal Probe Green: Low Risk of False Test Results

Cytocell recalls Aquarius LPH 511-A CRLF2 Distal Probe Green due to potential false lab test results. This may cause normal samples to be incorrectly reported as abnormal in certain tests.

🇺🇸 FDA recall #Z-1099-2021Medical deviceCytocell ›
Take action

Contact the company

Recalling firmCytocell Ltd.418 Cambridge Science Park, Milton Road, Oxford Gene Technology · Cambridge, United Kingdom
✎ GovInfoNow plain-language explainer

Cytocell is recalling its Aquarius LPH 511-A CRLF2 Distal Probe Green for possible false lab test results. This could lead to normal samples being incorrectly reported as abnormal in certain laboratory tests. Read more at govinfonow.com/recall/63624-cytocell-aquarius-lph-511-a-crlf2-distal-probe-green-low.

Source Summary by GovInfoNow · govinfonow.com/recall/63624-cytocell-aquarius-lph-511-a-crlf2-distal-probe-green-low · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1099-2021

Cite this page

“Cytocell Aquarius LPH 511-A CRLF2 Distal Probe Green: Low Risk of False Test Results.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/63624-cytocell-aquarius-lph-511-a-crlf2-distal-probe-green-low. Based on FDA recall #Z-1099-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1099-2021%22&limit=1).

Cytocell Ltd. recalled the Aquarius LPH 511-A CRLF2 Distal Probe Green on Dec. 22, 2020, according to the FDA. The device may produce faint additional signals, risking incorrect test results in laboratory developed tests.

How to tell if you have it

  • Brand: Cytocell
  • Product: Aquarius LPH 511-A CRLF2 Distal Probe Green
  • Model no.: LPH 511-A
  • Lots: 072240, 071390, and 072693

The hazard

Users may observe very faint additional locus specific signals at 11q13. There is a low risk of a normal sample being reported as not normal in a resulting laboratory developed test (LDT) that utilizes the LPH511-A CRLF2 Distal Probe Green.

Context

GovInfoNow's records show Cytocell Ltd. has 12 other recalls on record since March 15, 2019. Other recent recalls of similar products include LH One Step Ovulation Test Device Recall (Nov. 22, 2025), Meridian Bioscience Revogene C. difficile Test Recall (Dec. 5, 2025), and Changchun Wancheng Bio-Electron UTI Test Strips Recall (Nov. 22, 2025).

How to tell if you have this one

Look for the Aquarius LPH 511-A CRLF2 Distal Probe Green, model number LPH 511-A. The product was sold in lots 072240, 071390, and 072693.

  • Brand
    Cytocell
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Product Lot Number

    Verify the lot number on the probe to see if it matches 072240, 071390, or 072693.

Where it went and when

Where it was distributed

Distributed in 7 states, and outside the U.S.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: yesWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: yesMNIllinois: yesILWisconsin: not listedWIMichigan: yesMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: yesNJConnecticut: not listedCTCalifornia: yesCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: yesTXFlorida: not listedFL

FDA distribution: “Domestic distribution to California, Illinois, Michigan, Minnesota, New Jersey, Texas, and Washington. Foreign distribution to Canada.” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: California, Illinois, Michigan, Minnesota, New Jersey, Texas, Washington.

Recall timeline

FDA terminated this recall 17 months after the firm started it.

1. Firm started the recall: Dec 22, 202012. FDA classified it Class II: Feb 8, 202123. Published in FDA’s Enforcement Report: Feb 17, 202134. FDA terminated the recall: Jun 7, 2022420202022
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1099-2021 (December 22, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1099-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA